Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) Despite news of losing the bid against Amneal Pharmaceuticals and having to remove incorrect patents for an inhaler product, shares of Teva ...

We recently compiled a list of the 10 Firms Kick Off 2025 Trading in The Red. In this article, we are going to take a look at where Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) stands against ...

Why Teva Pharmaceuticals Stock Blasted 6% Higher Today May 12, 2025 — 05:02 pm EDT Written by Eric Volkman for The Motley Fool -> ...

"Teva Pharmaceuticals USA and others misled the American people about the true dangers of opioids," Attorney General Letitia James, a Democrat, said in a news release.

Photo courtesy of Teva Pharmaceuticals Aug. 21 (UPI) -- Teva Pharmaceuticals has agreed to pay a $225 million fine, in a settlement with the Justice Department over criminal price-fixing charges.

Teva Pharmaceuticals' business and stock price have been declining for years, but there are hints that a turnaround is in progress. Contrarian investors who buy in now have the potential to ...

Home> Health Care> Teva Pharmaceuticals scores win in patent infringement suit Teva Pharmaceuticals scores win in patent infringement suit Kimberly Redmond // January 9, 2024 // Listen to this article ...

In the red hot market for pharmaceutical deal-making it's either eat or be eaten. That's the case with Teva Pharmaceutical's $82 a share cash and stock bid for generic competitor Mylan on Tuesday ...

Topline Teva Pharmaceuticals will shell out as much as much as $523 million in New York to settle claims that the company contributed to the opioid crisis that has killed nearly half a million ...

Contacts Teva Pharmaceutical Industries Ltd. IR: United States Kevin C. Mannix, 215-591-8912 or United States Ran Meir, 215-591-3033 or Israel Tomer Amitai, 972 (3) 926-7656 or PR: Israel Iris ...